These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31728440)

  • 1. The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling.
    NTD Modelling Consortium Lymphatic Filariasis Group
    Gates Open Res; 2019; 3():1538. PubMed ID: 31728440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.
    Addiss D;
    Parasit Vectors; 2010 Oct; 3():100. PubMed ID: 20961435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of lymphatic filariasis: current perspectives on mass drug administration.
    Gyapong JO; Owusu IO; da-Costa Vroom FB; Mensah EO; Gyapong M
    Res Rep Trop Med; 2018; 9():25-33. PubMed ID: 30050352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The story of Lymphatic Filariasis elimination as a public health problem from Yemen.
    Al-Kubati AS; Al-Samie AR; Al-Kubati S; Ramzy RMR
    Acta Trop; 2020 Dec; 212():105676. PubMed ID: 32828916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.
    Clark J; Stolk WA; Basáñez MG; Coffeng LE; Cucunubá ZM; Dixon MA; Dyson L; Hampson K; Marks M; Medley GF; Pollington TM; Prada JM; Rock KS; Salje H; Toor J; Hollingsworth TD
    Gates Open Res; 2021; 5():112. PubMed ID: 35169682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY
    Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A; Graves PM; Lau C; Shaw C; Glass K
    Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
    Devi RR; Raju V
    J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination.
    Chimfwembe K; Shirley H; Baker N; Wamai R
    Trop Med Infect Dis; 2024 Jan; 9(1):. PubMed ID: 38251218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions to the lymphatic filariasis elimination programme and post-elimination surveillance in China by NIPD-CTDR.
    Sun DJ; Fang Y; Huang Y; Zhang Y
    Adv Parasitol; 2020; 110():145-183. PubMed ID: 32563324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity.
    Molyneux D
    Filaria J; 2003 Sep; 2(1):13. PubMed ID: 13129436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
    Kapa DR; Mohamed AJ
    Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis in Fiji: progress towards elimination, 1997-2007.
    Manolas RK; Kama M; Rainima-Qaniuci M; Bechu VD; Tuibeqa S; Winston MV; Ram N; Naqio F; Ichimori K; Capuano C; Ozaki M; Kim SH; Aratchige P; Sahukhan A; Graves PM
    Trop Med Health; 2020; 48():88. PubMed ID: 33132735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review.
    Srividya A; Subramanian S; Jambulingam P; Vijayakumar B; Dinesh Raja J
    Res Rep Trop Med; 2019; 10():43-90. PubMed ID: 31239804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity hotspot surveillance: A novel approach to detect lymphatic filariasis transmission in non-endemic areas of the Tillabéry region of Niger.
    Badia-Rius X; Adamou S; Taylor MJ; Kelly-Hope LA
    Parasite Epidemiol Control; 2023 May; 21():e00300. PubMed ID: 37138586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A game-theoretic model of lymphatic filariasis prevention.
    Rychtář J; Taylor D
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010765. PubMed ID: 36137005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling: NTD Modelling Consortium Onchocerciasis Group.
    NTD Modelling Consortium Onchocerciasis Group
    Gates Open Res; 2019; 3():1545. PubMed ID: 31723729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.